Skip to main content
News > Blog > Open Therapeutics Founder/Chair, Jason E. Barkeloo, to attend 2020 Asian Financial Forum, Hong Kong Convention and Exhibition Centre, January 13-14, 2020, Hong Kong SAR

Open Therapeutics Founder/Chair, Jason E. Barkeloo, to attend 2020 Asian Financial Forum, Hong Kong Convention and Exhibition Centre, January 13-14, 2020, Hong Kong SAR

Jason E. Barkeloo will attend invitation-only blockchain open science meetings, which will include meeting ultra high networth investors.

These meetings are inline with Open Therapeutics emerging product offering that uses blockchain in its management of grant funding.

This is embodied in the Company’s U.S. non-provisional patent filing US 2019 / 0080369 A1 (20190080369).

This patent filing enables grant funders to issue grants using the Company’s https://Therapoid.net platform and the technology manages the grant from start to finish, in conjunction with the scientific community. This technology will significantly reduce the time and cost of the grant funder’s funding process.

The Company was selected to attend at no cost by the Hong Kong Trade Development Council (HKTDC).

More about the 2020 Asian Financial Forum conference is at:  http://www.hktdc.com/ncs/aff2020/en/main/index.html.

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is pushing forward research that ordinarily would not generate a public value while particularly helping underserved scientists to collaborate.

How open science helps researchers succeed
Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers. We review literature demonstrating that open research is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open research practices bring significant benefits to researchers relative to more traditional closed practices.